Celexa and Haematuria aggravated - a phase IV clinical study of FDA data
We study 49,099 people who have side effects when taking Celexa. Haematuria aggravated is found, especially among people who are female, 60+ old, have been taking the drug for 6 - 12 months, also take Zometa and have Pain.
The phase IV clinical study analyzes which people take Celexa and have Haematuria aggravated. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
49,099 people reported to have side effects when taking Celexa.
Among them, 229 people (0.47%) have Haematuria aggravated.
What is Celexa?
Celexa has active ingredients of citalopram hydrobromide. It is used in depression. Currently, eHealthMe is studying from 55,833 Celexa users.
What is Haematuria aggravated?
Haematuria aggravated (presence of blood in urine) is found to be associated with 2,659 drugs and 1,370 conditions by eHealthMe. Currently, we are studying 3 people who have Haematuria aggravated.
Number of Celexa and Haematuria aggravated reports submitted per year:
Time on Celexa when people have Haematuria aggravated *:
Gender of people who have Haematuria aggravated when taking Celexa*:
Age of people who have Haematuria aggravated when taking Celexa *:
Common drugs people take besides Celexa *:
Common side effects people have besides Haematuria aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Celexa and have Haematuria aggravated?Check whether Haematuria aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
Celexa side effects by duration, gender and age:
- Celexa side effects (55,833 reports)
Haematuria aggravated treatments and more:
- Haematuria aggravated (3 reports)
Common drugs associated with Haematuria aggravated:
- Xarelto: 5,833 reports
- Aspirin: 4,194 reports
- Prednisone: 2,050 reports
- Omeprazole: 1,840 reports
- Metformin: 1,705 reports
- Furosemide: 1,698 reports
- Pantoprazole: 1,476 reports
- Pradaxa: 1,470 reports
- Simvastatin: 1,331 reports
- Coumadin: 1,326 reports
All the drugs that are associated with Haematuria aggravated:
- Haematuria aggravated (2,659 drugs)
Common conditions associated with Haematuria aggravated:
- Atrial fibrillation/flutter: 5,637 reports
- Stroke: 3,770 reports
- High blood pressure: 2,281 reports
- Deep venous thrombosis: 1,666 reports
- Pulmonary embolism: 1,083 reports
All the conditions that are associated with Haematuria aggravated:
- Haematuria aggravated (1,370 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on citalopram hydrobromide (the active ingredients of Celexa) and Celexa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Rosuvastatin Calcium and Marine Triglyceride drug interaction - a second ago
- Lurasidone Hydrochloride and Invega Sustenna drug interaction - 6 seconds ago
- Sunitinib Malate and Alginate drug interaction - 16 seconds ago
- Effexor Xr and Lumbar Spinal Stenosis - 21 seconds ago
- Isosorbide Dinitrate and Bydureon drug interaction - 25 seconds ago
- Imbruvica and Amitiza drug interaction - 28 seconds ago
- Relafen and Humulin 70/30 drug interaction - 30 seconds ago
- Neurontin and Application Site Irritation - 33 seconds ago
- Clinoril and Benicar drug interaction - 34 seconds ago
- Amlodipine and Conjunctival Hyperaemia - 35 seconds ago